Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Reportable Segments
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).
- Current Ratio
- The current ratio demonstrates considerable fluctuations over the observed periods. Starting at 1.87, it initially increases, reaching a peak of 2.91 in October 2021, indicating improving short-term liquidity. However, from this peak, it declines sharply to 1.58 in July 2022, showing a reduction in the company’s ability to meet short-term obligations with current assets. Following this dip, there is a recovery trend, with the ratio stabilizing around the 2.3 mark in late 2023 before experiencing minor volatility and settling near 2.01 by July 2025. Overall, the current ratio reflects periods of both strengthening and weakening liquidity with some recent stabilization slightly above 2.0.
- Quick Ratio
- The quick ratio follows a similar pattern to the current ratio, signifying a parallel trend in the company’s liquid assets excluding inventory. Beginning at 1.37, it climbs steadily to a peak of 2.07 in October 2021, consistent with improved immediate liquidity. Subsequently, a pronounced decline occurs, reaching a low of 1.01 in July 2022, indicating a tightening position in liquid assets. Thereafter, a gradual recovery phase takes place, with the ratio fluctuating modestly and ending at approximately 1.25 by July 2025. This fluctuation suggests that while liquidity without inventory decreased significantly mid-period, there has been notable improvement, though not back to prior peaks.
- Cash Ratio
- The cash ratio shows a less pronounced but notable variation. From 0.99 initially, it trends upward to 1.37 by October 2021, indicating an enhanced cushion of cash and cash equivalents. Following this peak, a sharper decline to 0.63 in July 2022 is observed, highlighting diminished immediate cash availability relative to short-term liabilities. The ratio then exhibits moderate recovery but remains below the earlier peak, oscillating between 0.7 and 0.88 before settling at 0.7 by July 2025. This suggests that actual cash reserves relative to liabilities are more constrained in the latter periods compared to the earlier highs.
- Overall Liquidity Analysis
- The liquidity ratios collectively illustrate a pattern of improvement during the first part of the timeline, culminating in peaks around October 2021. This was followed by a marked deterioration through mid-2022, reflecting potentially increased short-term liabilities or reduced liquid assets. In subsequent periods, a trend toward recovery and stabilization occurs, though not all ratios return to previous heights. The current and quick ratios show relatively stronger recovery compared to the cash ratio, which remains subdued. These dynamics may indicate strategic adjustments in working capital management or changing operational cash flows impacting liquidity positions over time.
Current Ratio
| Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Current assets | ||||||||||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Current ratio1 | ||||||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Current Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).
1 Q1 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The analysis of the quarterly financial data reveals several notable trends in liquidity as reflected by the current assets, current liabilities, and the current ratio over the observed periods.
- Current Assets
- The value of current assets fluctuated throughout the quarters without a strong directional trend. Starting from approximately $24.5 billion, the values peaked intermittently around $25.4 billion but also experienced troughs near $21.7 billion. More recently, the asset levels have stabilized near the range of $22.3 billion to $23.8 billion, indicating a modest recovery after several declines.
- Current Liabilities
- Current liabilities showed a variable pattern, initially decreasing from about $13.1 billion to a low near $7.8 billion, suggesting improved short-term obligations management in early periods. However, this was followed by a notable increase, peaking over $14.4 billion, before subsequently declining to approximately $11.5 billion in the latest quarters. The fluctuations suggest periods of varying liability accumulation and repayment strategies.
- Current Ratio
- The current ratio, which measures the ability to cover short-term liabilities with current assets, demonstrated significant volatility. It rose from 1.87 to a high near 2.91, indicating a strong liquidity position in some quarters. Nevertheless, it dropped sharply to lows around 1.58, reflecting tighter liquidity in other quarters. More recent values stabilize around a range of 1.85 to 2.42, signifying a moderately healthy liquidity position with sufficient current assets to cover current liabilities, albeit with periods of relative constraint.
Overall, the data suggest the company maintains a generally adequate liquidity buffer to meet immediate obligations but experiences periodic fluctuations likely influenced by operational cycles or strategic financial management actions. The variability in the current ratio points to adjustments made in working capital components. The pattern indicates responsiveness to financial conditions, with a tendency toward maintaining a ratio comfortably above 1.5, which is generally viewed as a safeguard against liquidity risks.
Quick Ratio
| Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||||||||||
| Investments | ||||||||||||||||||||||||||||
| Accounts receivable, less allowances and credit losses | ||||||||||||||||||||||||||||
| Total quick assets | ||||||||||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Quick ratio1 | ||||||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).
1 Q1 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The company's liquidity position, as reflected by the quick ratio, has experienced notable fluctuations throughout the observed periods. Initially, the quick ratio showed an upward trend, increasing from 1.37 to a peak around 2.07 between mid-2020 and late 2021, indicating a strengthening in the company's ability to cover its current liabilities with its most liquid assets.
Following this peak, the ratio declined steadily, reaching levels close to 1.0 by mid-2022, signaling a reduced margin of safety in meeting short-term obligations. From this low point, there was a moderate recovery, with the ratio stabilizing around 1.2 to 1.5 during 2023 and into 2024, though it remained below the earlier peak values.
Total quick assets showed variability, with the highest values recorded in late 2020 and early 2021, followed by a decline through 2022, bottoming out in mid-2023. Subsequent quarters revealed some recovery, but total quick assets generally did not return to previous peak levels. This trend suggests cautious management of liquid resources, possibly responding to changes in operational needs or market conditions.
Current liabilities displayed an uneven pattern. A significant decrease occurred in mid-2021, dropping from approximately US$13 billion to below US$8 billion. However, liabilities then rose sharply again through late 2021 and 2022, exceeding previous levels. The latter periods showed relatively high and fluctuating liabilities, with amounts generally oscillating between US$9 billion and US$12.8 billion. This volatility indicates variable short-term obligations, which could reflect shifting financial strategies or operational activities impacting working capital management.
Overall, the analysis suggests that the firm experienced a period of strong liquidity early in the dataset, followed by more constrained conditions during 2022 and partial recovery thereafter. The fluctuations in quick assets and current liabilities influenced the quick ratio trends, highlighting challenges in maintaining consistent liquidity levels. The company maintained a quick ratio above 1.0 throughout, indicating a continuing ability to meet short-term obligations without relying on inventory sales, albeit with varying degrees of comfort.
Cash Ratio
| Jul 25, 2025 | Apr 25, 2025 | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||||||||||
| Investments | ||||||||||||||||||||||||||||
| Total cash assets | ||||||||||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Cash ratio1 | ||||||||||||||||||||||||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | ||||||||||||||||||||||||||||
| Elevance Health Inc. | ||||||||||||||||||||||||||||
| Intuitive Surgical Inc. | ||||||||||||||||||||||||||||
| UnitedHealth Group Inc. | ||||||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).
1 Q1 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
- Total Cash Assets
- The total cash assets demonstrated fluctuations throughout the observed periods. Initially, there was an increase from approximately 13,012 million USD to a peak above 14,000 million USD by early 2021. Subsequently, a decline occurred reaching a trough near 7,734 million USD in late 2023. Although some recovery was noted thereafter, the amounts remained generally below the earlier peak, evidencing volatility and an overall mild downward tendency over the full timeframe examined.
- Current Liabilities
- Current liabilities showed a decreasing trend during the first half of the period, dropping from about 13,086 million USD down to below 8,000 million USD in mid-2021. Following this period, liabilities increased sharply and exhibited a notably rising pattern, peaking above 14,000 million USD in late 2022 and sustaining relatively high values with some fluctuations around 11,000 to 12,000 million USD toward the end of the timeline.
- Cash Ratio
- The cash ratio started close to 1.0, indicating near parity between cash assets and current liabilities. This ratio improved slightly to above 1.3 in mid-2021, suggesting a stronger liquidity position during that phase. However, thereafter, the ratio declined consistently, falling below 0.7 in several of the latest quarters. This decline points to a deterioration in immediate liquidity, implying that cash assets covered a progressively smaller fraction of current liabilities over time.
- Overall Analysis
- The data reveal an overall decrease and variability in cash asset levels coupled with an increase in current liabilities over several consecutive quarters, leading to a diminished cash ratio. This combination suggests increasing pressure on the company's short-term liquidity, potentially warranting close monitoring or strategic response aimed at improving cash reserves or managing liabilities more effectively to sustain adequate liquidity.